Effect of recombinant mouse interferon-β on acute and latent herpes simplex infection in mice

Masao Yamada, Yujiro Arao, A. Hatano, F. Uno, S. Nii

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The antiviral effect of recombinant mouse interferon-β(rMuIFN-β) on herpes simplex virus type 1 (HSV-1) in experimentally infected mice was examined at several stages of infection as a model for the treatment of human HSV infection. Recombinant MuIFN-β protected mice from lethal intraperitoneal challenge with virulent HSV-1 strains. The in vitro reactivation of HSV from latently infected trigeminal ganglia was also suppressed by treatment with rMuIFN-β. Thus, rMuIFN-β was effective against HSV-1 during acute infection and during in vitro reactivation of latent HSV. However, rMuIFN-β was not effective in preventing the establishment of latent infection, or in eliminating a previously established latent infection.

Original languageEnglish
Pages (from-to)101-109
Number of pages9
JournalArchives of Virology
Volume99
Issue number1-2
DOIs
Publication statusPublished - Mar 1988

Fingerprint

Herpes Simplex
Interferons
Human Herpesvirus 1
Infection
Trigeminal Ganglion
Antiviral Agents

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Genetics

Cite this

Effect of recombinant mouse interferon-β on acute and latent herpes simplex infection in mice. / Yamada, Masao; Arao, Yujiro; Hatano, A.; Uno, F.; Nii, S.

In: Archives of Virology, Vol. 99, No. 1-2, 03.1988, p. 101-109.

Research output: Contribution to journalArticle

@article{337eb31252e741d1813051796bcb9fa9,
title = "Effect of recombinant mouse interferon-β on acute and latent herpes simplex infection in mice",
abstract = "The antiviral effect of recombinant mouse interferon-β(rMuIFN-β) on herpes simplex virus type 1 (HSV-1) in experimentally infected mice was examined at several stages of infection as a model for the treatment of human HSV infection. Recombinant MuIFN-β protected mice from lethal intraperitoneal challenge with virulent HSV-1 strains. The in vitro reactivation of HSV from latently infected trigeminal ganglia was also suppressed by treatment with rMuIFN-β. Thus, rMuIFN-β was effective against HSV-1 during acute infection and during in vitro reactivation of latent HSV. However, rMuIFN-β was not effective in preventing the establishment of latent infection, or in eliminating a previously established latent infection.",
author = "Masao Yamada and Yujiro Arao and A. Hatano and F. Uno and S. Nii",
year = "1988",
month = "3",
doi = "10.1007/BF01311027",
language = "English",
volume = "99",
pages = "101--109",
journal = "Archives of Virology",
issn = "0304-8608",
publisher = "Springer Wien",
number = "1-2",

}

TY - JOUR

T1 - Effect of recombinant mouse interferon-β on acute and latent herpes simplex infection in mice

AU - Yamada, Masao

AU - Arao, Yujiro

AU - Hatano, A.

AU - Uno, F.

AU - Nii, S.

PY - 1988/3

Y1 - 1988/3

N2 - The antiviral effect of recombinant mouse interferon-β(rMuIFN-β) on herpes simplex virus type 1 (HSV-1) in experimentally infected mice was examined at several stages of infection as a model for the treatment of human HSV infection. Recombinant MuIFN-β protected mice from lethal intraperitoneal challenge with virulent HSV-1 strains. The in vitro reactivation of HSV from latently infected trigeminal ganglia was also suppressed by treatment with rMuIFN-β. Thus, rMuIFN-β was effective against HSV-1 during acute infection and during in vitro reactivation of latent HSV. However, rMuIFN-β was not effective in preventing the establishment of latent infection, or in eliminating a previously established latent infection.

AB - The antiviral effect of recombinant mouse interferon-β(rMuIFN-β) on herpes simplex virus type 1 (HSV-1) in experimentally infected mice was examined at several stages of infection as a model for the treatment of human HSV infection. Recombinant MuIFN-β protected mice from lethal intraperitoneal challenge with virulent HSV-1 strains. The in vitro reactivation of HSV from latently infected trigeminal ganglia was also suppressed by treatment with rMuIFN-β. Thus, rMuIFN-β was effective against HSV-1 during acute infection and during in vitro reactivation of latent HSV. However, rMuIFN-β was not effective in preventing the establishment of latent infection, or in eliminating a previously established latent infection.

UR - http://www.scopus.com/inward/record.url?scp=0023932795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023932795&partnerID=8YFLogxK

U2 - 10.1007/BF01311027

DO - 10.1007/BF01311027

M3 - Article

C2 - 3355371

AN - SCOPUS:0023932795

VL - 99

SP - 101

EP - 109

JO - Archives of Virology

JF - Archives of Virology

SN - 0304-8608

IS - 1-2

ER -